Rootup

FDA 21 CFR Part 11

Title 21 of the Code of Federal Regulations, Part 11, sets the conditions under which the Food and Drug Administration (FDA) considers electronic records and electronic signatures trustworthy, reliable and equivalent to paper records and handwritten signatures.

It applies to records required by other FDA regulations, such as good manufacturing practices. It is the U.S. counterpart of Health Canada's Annex 11; a single validation approach, for example following GAMP 5, often addresses both.

At a glance
Regulator
U.S. Food and Drug Administration (FDA)
Applies to
FDA-regulated companies (drugs, medical devices, biologics, etc.) that keep required records electronically, including foreign companies exporting to the United States
Structure
Subpart B: electronic records; Subpart C: electronic signatures
FDA guidance
"Part 11, Electronic Records; Electronic Signatures — Scope and Application" (2003), which favours a risk-based approach

Key requirements

System validation (11.10(a))

Systems must be validated to ensure accuracy, reliability and the ability to discern invalid or altered records.

Copies and retention (11.10(b) and (c))

Generate accurate and complete copies for inspection, and protect records so they remain retrievable throughout the retention period.

Access control (11.10(d))

Only authorized individuals can access the system.

Audit trails (11.10(e))

Secure, computer-generated, time-stamped audit trails recording the creation, modification and deletion of records without obscuring previous values.

Checks and training (11.10(f) to (k))

Operational, authority and device checks, user training, accountability policies and control of system documentation.

Electronic signatures (Subpart C)

Signatures unique to each individual, linked to the signed record, showing name, date, time and meaning, with two identification components and a certification submitted to the FDA.

Penalties and risks

  • Observations on FDA Form 483 during inspections
  • Public warning letters
  • Import alerts and refusal of products at the border for foreign companies
  • Questions about the reliability of the data and of the affected batches

How Rootup helps

  • Assessment of your computerized systems against Part 11
  • Validation following GAMP 5: plan, risk assessment, protocols and reports
  • Configuration of audit trails, access and electronic signatures
  • Backup and retention of electronic records
  • IT procedures and FDA inspection readiness

This information is provided for general purposes and does not constitute legal advice. For an analysis of your situation, consult a legal advisor.

Compliance

United States

Have Questions?

Have Questions?

Contact Us

Talk to our sales expert

1-855-561-3655info@rootup.io
Rootup

Rooted in security. Built for growth.

Root Up Inc.
2915 Ogletown Road, #4632
Newark, DE 19713, USA
3580 rue Isabelle suite #110
Brossard, Québec J4Y 2R3, Canada
© 2026 Root Up Canada Inc. and Root Up Inc. All rights reserved.